lactococcu
lacti
select
antigen
deliveri
vehicl
mucos
immun
porcin
transmiss
gastroenter
viru
tgev
infect
approxim
kda
fragment
ntermin
globular
domain
spike
protein
n
protein
coronaviru
tgev
use
transmiss
gastroenter
viru
antigen
model
recombin
l
lacti
express
n
protein
construct
plasmid
express
local
transcrib
n
protein
recombin
l
nz
n
detect
via
sdspage
western
blot
immunofluoresc
balbc
mice
oral
immun
l
nz
n
produc
local
mucos
immun
respons
tgev
induc
antibodi
demonstr
neutral
effect
tgev
infect
data
indic
recombin
l
lacti
could
valuabl
tool
develop
futur
vaccin
tgev
research
carri
recent
year
led
convict
certain
strain
lactic
acid
bacteria
lab
particular
strain
genera
lactobacillu
bifidobactrium
may
promot
health
man
anim
lab
possess
number
properti
make
attract
candid
oral
vaccin
purpos
bacteria
consid
safe
organ
gra
gener
recogn
safe
statu
addit
lactobacilli
abl
surviv
passag
upper
gastrointestin
tract
git
certain
strain
capabl
colon
intestin
tract
properti
particularli
relev
vaccin
appli
less
industri
countri
furthermor
mani
bacteri
viral
parasit
pathogen
enter
bodi
via
mucos
surfac
bodi
first
line
defens
human
anim
found
surprisingli
intestin
largest
immunolog
organ
human
bodi
antibodi
produc
daili
secret
git
oral
immun
frequent
evok
local
system
immun
respons
result
effect
elimin
foreign
invad
characterist
make
attract
candid
deliv
pharmaceut
compound
interest
mucosa
particularli
vaccin
immunomodul
transmiss
gastroenter
viru
tgev
coronaviru
caus
highli
contagi
enter
diseas
pig
result
neonat
mortal
sever
econom
lose
affect
farm
viral
genom
consist
singlestrand
positivesens
kb
rna
construct
three
major
structur
protein
n
fourth
structur
protein
small
membran
sm
protein
protein
major
induc
tgev
neutral
antibodi
protein
use
mainli
induct
protect
immun
tgev
relev
neutral
epitop
map
ntermin
domain
protein
four
major
antigen
site
describ
glycoprotein
site
immunodomin
protect
suckl
piglet
tgev
infect
base
uptak
specif
lactogen
antibodi
mainli
iga
class
milk
tgevimmun
sow
present
articl
use
lactococcu
lacti
vector
express
ntermin
globular
domain
spike
protein
act
antigen
carrier
oral
vaccin
data
indic
intragastr
inocul
recombin
bacteria
l
nz
n
could
induc
specif
immun
respons
tgev
lactococcu
lacti
grown
medium
contain
glucos
requir
antibiot
chloramphenicol
ad
lgml
l
lacti
unless
otherwis
state
plate
bacteria
perform
medium
agar
antibiot
concentr
use
select
lactococcu
transform
lgml
chloromycetin
cm
sigma
st
loui
mo
label
lactococcu
cfdase
lactococcu
lacti
label
carboxyfluorescein
diacet
succinimidyl
ester
cfdase
molecular
probesinvitrogen
carlsbad
ca
sigma
nonfluoresc
membraneperm
ester
convert
fluoresc
deriv
nonspecif
prokaryoticeukaryot
intracellular
esteras
deriv
coval
link
intracellular
protein
via
probe
succinimidyl
group
briefli
mm
stock
solut
cfdase
dissolv
dimethyl
sulfoxid
dilut
ethanol
ml
reagent
grade
solut
filtersteril
aliquot
store
l
lacti
grown
overnight
medium
contain
glucos
bacteri
cultur
centrifug
min
pellet
wash
twice
steril
pb
adjust
concentr
cfuml
label
cfdase
min
fluoresc
label
termin
pellet
bacteria
label
bacteria
wash
twice
steril
pb
remov
excess
cfdase
resuspend
steril
pb
flow
cytometri
profil
fac
calibur
tm
bd
bioscienc
cell
quest
tm
pro
show
cell
label
sevenweekold
balbc
mice
obtain
laboratori
anim
center
harbin
medic
univers
china
group
mice
dose
approxim
cfdaselabel
bacteria
oral
administr
anoth
group
mice
oral
fed
steril
pb
control
group
three
mice
kill
day
duodenum
jejunum
ileum
colon
extract
mous
individu
section
cut
longitudin
residu
food
particl
fecal
materi
remov
intestin
examin
presenc
adher
cfdaselabel
bacteria
perform
ad
pb
everi
cm
tissu
dislodg
microb
mucos
surfac
tissu
cell
extract
fix
formaldehyd
vv
prior
flow
cytometri
analysi
construct
tgev
n
gene
express
plasmid
tgev
strain
isol
store
laboratori
dna
manipul
perform
accord
standard
procedur
plasmid
use
present
studi
cellsurfac
express
vector
contain
secret
signal
peptid
anchor
domain
structur
gift
nizo
netherland
fragment
gene
encod
tgev
antigen
encompass
four
major
antigen
neutral
epitop
obtain
rtpcr
tgev
genom
oligonucleotid
cttgcatg
forward
contain
sphi
site
cgtctagac
acaccactattatcagacggtacacccactatgtt
revers
contain
xbai
site
pcr
amplif
condit
follow
min
cycl
min
min
min
min
final
extens
pcr
product
digest
sphi
xbai
insert
correspond
site
gener
recombin
l
lacti
tgev
n
protein
electropor
carri
accord
method
describ
josson
et
al
holo
ne
modif
briefli
recombin
plasmid
dna
ad
l
lacti
gentli
mix
place
min
mixer
subject
singl
electr
puls
lf
vcm
resuspend
medium
without
antibiot
incub
anaerob
condit
h
recombin
strain
select
medium
viru
gene
contain
lgml
cm
presenc
integr
construct
check
extract
recombin
plasmid
dna
restrict
enzym
analysi
sequenc
segreg
structur
stabil
n
assess
segreg
stabil
n
l
lacti
recombin
strain
grown
medium
without
cm
serial
subcultur
perform
dilut
cultur
fresh
broth
without
antibiot
grow
midexponenti
phase
reach
gener
percentag
cmresist
cm
r
coloni
determin
plate
cultur
dilut
onto
plate
without
cm
plate
supplement
lgml
cm
determin
structur
stabil
recombin
plasmid
gener
sever
coloni
randomli
pick
plate
analyz
coloni
pcr
use
forward
revers
primer
gene
analyz
express
local
n
fusion
protein
overnight
cultur
strain
l
nz
n
plasmid
introduc
fresh
medium
ratio
induct
nisa
promot
strain
grown
optic
densiti
nm
nisin
sigma
ad
final
concentr
ngml
growth
continu
h
growth
continu
without
addit
nisin
optic
densiti
nm
reach
prepar
extract
cell
pellet
centrifug
min
bacteri
pellet
wash
twice
steril
mm
triscl
ph
lyse
beadbeat
biospec
bartlesvil
usa
vigor
shake
lysat
centrifug
min
supernat
store
analysi
bacteri
protein
extract
supernat
examin
use
sdspage
protein
electrotransf
onto
nitrocellulos
membran
immunoblot
develop
use
mous
antitgev
serum
antiserum
obtain
balbc
mice
immun
tgev
horseradish
peroxidas
hrp
conjug
goat
antimous
igg
sigma
use
visual
immunolabel
band
carri
use
chemiluminesc
substrat
reagent
pierc
accord
manufactur
instruct
immunofluoresc
also
use
analyz
cellsurfac
display
n
protein
induc
bacteri
cultur
l
rtgev
n
ml
pellet
wash
twice
steril
pb
resuspend
pb
contain
mous
anti
serum
incub
h
cell
centrifug
wash
twice
steril
pb
remov
unbound
antibodi
pellet
incub
fitcconjug
goat
antimous
igg
sigma
contain
evan
blue
dye
pierc
h
cell
wash
twice
steril
pb
resuspend
steril
pb
laid
glass
slide
confoc
microscopi
use
visual
fluoresc
cell
surfac
l
rtgev
n
strain
lactococcu
lacti
harbor
plasmid
widetyp
l
lacti
use
control
immun
l
rtgev
n
cultur
induc
nisin
centrifug
cell
pellet
wash
steril
pb
resuspend
pb
concentr
cfuml
treatment
group
mice
receiv
dose
cell
l
rtgev
n
control
mice
immun
equival
dose
l
lacti
sham
control
group
receiv
ml
dose
pb
mice
immun
via
oral
administr
immun
protocol
administ
three
consecut
day
day
booster
immun
given
day
second
booster
given
day
sera
prepar
store
requir
intestin
mucu
mice
extract
describ
previous
polystyren
microtit
plate
coat
tgev
propag
swine
testicular
st
cell
overnight
cultur
swine
testicular
st
cell
use
neg
control
antigen
elisa
plate
wash
twice
pb
contain
satur
pb
contain
skim
milk
h
serum
intestin
lavag
dilut
tenfold
pb
contain
bsa
primari
antibodi
incub
h
plate
wash
twice
pb
contain
bound
antibodi
detect
use
hrpconjug
goat
antimous
iga
igg
sigma
follow
color
develop
use
ophenylen
diamin
dihydrochlorid
sigma
substrat
absorb
measur
nm
endpoint
titer
concentr
antibodi
iga
igg
optic
densiti
od
taken
elisa
data
calcul
accord
raghava
et
al
intestin
fluid
serum
sampl
obtain
mice
immun
l
nz
n
evalu
use
plaqu
reduct
assay
determin
neutral
abil
lavag
serum
obtain
mice
fed
nonexpress
strain
pb
use
neg
control
sampl
twofold
serial
dilut
prepar
plate
tgev
adjust
viru
diluent
concentr
hank
balanc
salt
solut
bovin
serum
albumin
ph
ad
cell
plate
contain
serial
dilut
intestin
lavag
serum
antibodi
viru
mixtur
mix
incub
h
st
cell
use
viru
infect
ad
antibodyviru
mixtur
incub
co
day
overlay
medium
discard
well
wash
twice
steril
pb
ph
stain
crystal
violet
solut
differ
number
plaqu
form
treatment
examin
level
signific
determin
analysi
varianc
anova
follow
student
ttest
persist
l
lacti
intestin
tract
determin
via
oral
administr
cfdaselabel
lactococcu
mice
sampl
differ
region
intestin
postorogastr
intub
flow
cytometr
analysi
cell
extract
tabl
indic
lactococcu
abl
surviv
adher
differ
region
intestin
tract
adhes
promin
ileum
cell
detect
first
day
seventh
day
amount
l
lacti
remain
adher
intestin
mucosa
observ
first
day
duodenum
jejunum
ileum
colon
respect
gene
encod
n
protein
amplifi
clone
sphixbai
fragment
correspond
site
express
plasmid
gener
n
fig
recombin
plasmid
electropor
l
lacti
produc
recombin
strain
l
nz
n
l
nz
n
coloni
grown
overnight
basal
medium
induc
nisin
cell
fig
lane
neg
control
l
lacti
display
correspond
immunoreact
band
fig
lane
result
show
nisin
promot
could
effici
induc
express
tgev
heterolog
protein
immunofluoresc
assay
develop
mous
antitgev
serum
fitc
fluorescenceconjug
goat
antimous
igg
confirm
cellsurfac
display
n
fusion
protein
result
indic
greenyellow
fluoresc
cell
surfac
l
nz
n
fig
control
bacteria
red
determin
evan
blue
dye
fig
local
analysi
result
suggest
n
protein
could
expos
extern
cell
wall
protein
could
detect
supernat
induc
cultur
l
nz
n
even
concentr
supernat
millipor
column
data
shown
next
segreg
structur
stabil
n
l
lacti
analyz
gener
subcultur
broth
without
cm
result
indic
recombin
plasmid
stabl
maintain
cm
r
phenotyp
structur
arrang
thu
recombin
lactococcu
could
still
express
protein
interest
fig
mucos
immun
respons
investig
measur
antitgev
n
iga
level
intestin
lavag
follow
intragastr
immun
concentr
mucos
iga
tgev
n
determin
elisa
use
tgev
cultur
coat
antigen
result
show
substanti
differ
mucos
iga
level
experiment
control
group
prior
intragastr
immun
howev
oral
immun
recombin
l
nz
n
elicit
antigenspecif
mucos
iga
respons
second
booster
high
level
antitgev
n
iga
observ
intestin
lavag
mice
immun
l
nz
n
fig
wherea
anti
n
specif
iga
detect
control
st
cell
cultur
use
neg
control
antigen
anti
n
specif
iga
detect
data
fig
plaqu
reduct
assay
perform
detect
whether
antibodi
respons
specif
tgev
antigen
result
demonstr
presenc
antitgev
n
iga
igg
cultur
medium
confer
statist
signific
neutral
effect
p
tgev
infect
fig
consist
reduct
number
plaqu
observ
plaqu
reduct
assay
carri
use
twoto
eightfold
dilut
sera
reduct
seen
twoto
eightfold
dilut
intestin
lavag
obtain
mice
immun
l
nz
n
inhibitori
effect
decreas
gradual
dilut
reach
level
similar
buffer
control
nonexpress
control
strain
dilut
intestin
lavag
sera
respect
report
found
globular
part
ntermin
domain
tgev
spike
protein
glycoprotein
express
l
lacti
retain
antigen
properti
elicit
neutral
antibodi
use
immun
anim
mani
pathogen
initi
infect
mainli
occur
mucosa
tissu
intestin
therefor
import
develop
vaccin
elicit
protect
immun
respons
infect
replic
pathogen
mucos
level
vaccin
administ
parenter
rout
gener
fail
stimul
mucos
immun
respons
mucos
immun
proven
effect
approach
colon
pathogen
spread
system
circul
therefor
necessari
develop
effici
safe
antigen
vector
could
trigger
mucos
system
immun
respons
one
promis
approach
reli
use
live
bacteri
vehicl
potenti
recombin
lab
deliv
heterolog
antigen
mucos
immun
system
investig
approach
offer
number
advantag
tradit
parenter
vaccin
noninvas
possibl
elicit
mucos
system
immun
respons
great
deal
research
current
explor
oral
applic
focus
develop
adequ
mucos
vaccin
variou
vaccin
deliveri
system
among
avail
approach
effici
stimul
mucos
respons
use
lactococcu
carrier
deliv
vaccin
antigen
probabl
constitut
one
success
strategi
use
lab
live
vehicl
deliveri
antigen
therapeut
molecul
mucos
immun
propos
howev
system
describ
use
lactobacillu
casei
strain
carrier
heterolog
viral
antigen
form
present
process
mammalian
host
tgev
protein
express
lactobacillu
casei
lactobacillu
resid
strain
present
intestin
tract
mammal
may
produc
immunolog
toler
practic
applic
use
identifi
iga
predomin
antibodi
mucos
surfac
local
product
greater
immunoglobulin
therefor
effici
tgev
oral
vaccin
abl
induc
specif
mucos
iga
respons
evalu
immunogen
l
nz
n
use
balb
c
mice
anim
model
l
nz
n
produc
mucos
system
immun
respons
intragastr
administr
oral
administr
regimen
consist
three
set
three
success
daili
dose
l
nz
n
vaccin
protocol
adapt
challacomb
procedur
consist
effect
particul
oral
vaccin
use
immun
mice
three
success
daili
dose
recombin
bacteria
requir
order
ensur
system
antibodi
respons
tgev
could
elicit
mice
receiv
recombin
strain
intragastr
order
confirm
effici
induc
antibodi
inhibit
viru
test
whether
intestin
lavag
sera
could
inhibit
infect
st
cell
plaqu
reduct
assay
serum
intestin
sampl
collect
mice
immun
l
nz
n
demonstr
statist
signific
inhibit
import
featur
deliveri
system
abil
adher
persist
intestin
tract
lactobacilli
could
surviv
passag
upper
git
colon
intestin
tract
addit
lactobacilli
intrins
adjuv
activ
present
studi
investig
potenti
adhes
persist
mous
intestin
use
cfdase
shown
cfuml
cfuml
l
lacti
oral
fed
mice
adher
differ
section
intestin
tract
percentag
l
lacti
remain
differ
section
intestin
tract
initi
attach
first
day
vari
present
studi
demonstr
l
lacti
abl
surviv
upper
git
express
secret
heterolog
tgev
n
protein
induc
specif
immun
respons
oral
administr
current
process
confirm
immun
protect
recombin
lactococcu
express
tgev
n
protein
pig
also
investig
mechan
antigen
enter
intravascular
compart
induc
system
immun
respons
probiot
effect
harmless
natur
lactococcu
lacti
would
make
ideal
candid
deliv
heterolog
antigen
oral
vaccin
present
studi
describ
novel
approach
prevent
spread
transmiss
gastroenter
pig
describ
capabl
l
lacti
adher
git
believ
data
could
valuabl
intens
hostpathogen
interact
studi
prevent
tgev
outbreak
recombin
lactococcu
express
n
protein
induc
local
mucos
systemat
immun
respons
tgev
induc
antibodi
demonstr
neutral
effect
tgev
infect
data
indic
recombin
lactococcu
could
use
tool
develop
futur
vaccin
tgev
